Filing Details

Accession Number:
0001209191-22-046998
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-22 15:27:38
Reporting Period:
2022-08-19
Accepted Time:
2022-08-22 15:27:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1703057 Abcellera Biologics Inc. ABCL Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1834449 Ltd. Holdings Thermopylae 2215 Yukon Street
Vancouver A1
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2022-08-19 200,000 $11.46 55,844,391 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $11.20 to $11.59. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote.